# EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking

> **NCT03262662** · PHASE3 · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 320 (actual)

## Conditions studied

- Tobacco Smoking

## Interventions

- **DRUG:** Varenicline
- **BEHAVIORAL:** Brief smoking cessation counseling

## Key facts

- **NCT ID:** NCT03262662
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2021-04-05
- **Final completion:** 2021-07-08
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2025-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262662, "EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03262662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*